SG Americas Securities LLC Has $5.51 Million Stake in Xylem Inc. $XYL

SG Americas Securities LLC reduced its position in Xylem Inc. (NYSE:XYL) by 68.2% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 37,359 shares of the industrial products company’s stock after selling 80,278 shares during the period. SG Americas Securities LLC’s holdings in Xylem were worth $5,510,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. AQR Capital Management LLC grew its holdings in shares of Xylem by 14.4% during the first quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock valued at $3,645,000 after buying an additional 3,900 shares during the last quarter. NewEdge Advisors LLC lifted its position in Xylem by 3.3% in the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock valued at $496,000 after acquiring an additional 132 shares in the last quarter. Empowered Funds LLC boosted its stake in Xylem by 56.1% during the 1st quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock valued at $1,037,000 after purchasing an additional 3,120 shares during the last quarter. Focus Partners Wealth increased its holdings in Xylem by 217.4% during the 1st quarter. Focus Partners Wealth now owns 59,608 shares of the industrial products company’s stock worth $7,121,000 after purchasing an additional 40,827 shares in the last quarter. Finally, Strs Ohio bought a new stake in Xylem during the 1st quarter worth approximately $10,781,000. Institutional investors own 87.96% of the company’s stock.

Xylem Trading Down 0.9%

Shares of Xylem stock opened at $139.62 on Friday. The firm has a market cap of $33.99 billion, a PE ratio of 35.89, a P/E/G ratio of 1.98 and a beta of 1.17. Xylem Inc. has a 1 year low of $100.47 and a 1 year high of $154.27. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.96 and a quick ratio of 1.50. The stock has a fifty day moving average price of $141.08 and a 200-day moving average price of $140.73.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.23 by $0.14. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The company had revenue of $2.27 billion during the quarter, compared to analyst estimates of $2.22 billion. During the same quarter in the prior year, the business earned $1.11 earnings per share. The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. Equities research analysts anticipate that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 23rd. Stockholders of record on Tuesday, November 25th were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend was Tuesday, November 25th. Xylem’s dividend payout ratio is currently 41.13%.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on XYL shares. Citigroup raised their target price on Xylem from $173.00 to $182.00 and gave the company a “buy” rating in a report on Wednesday, October 29th. TD Cowen raised their price objective on Xylem from $130.00 to $135.00 and gave the company a “hold” rating in a research note on Friday, December 5th. Stifel Nicolaus lifted their price objective on shares of Xylem from $175.00 to $178.00 and gave the stock a “buy” rating in a report on Wednesday, October 29th. Wall Street Zen downgraded shares of Xylem from a “buy” rating to a “hold” rating in a report on Saturday, December 27th. Finally, Zacks Research lowered shares of Xylem from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. Eight research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $165.80.

Insider Activity at Xylem

In related news, EVP Claudia S. Toussaint sold 10,421 shares of Xylem stock in a transaction that occurred on Thursday, October 30th. The shares were sold at an average price of $152.64, for a total value of $1,590,661.44. Following the sale, the executive vice president owned 31,250 shares of the company’s stock, valued at approximately $4,770,000. The trade was a 25.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Victoria D. Harker sold 1,700 shares of the company’s stock in a transaction that occurred on Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total value of $251,838.00. Following the completion of the transaction, the director owned 16,875 shares in the company, valued at approximately $2,499,862.50. The trade was a 9.15% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.27% of the company’s stock.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.